Increased incidence of brain metastases in cutaneous head and neck melanoma

Melanoma Research

Volumn 15, Issue 2, 2005, Pages 119-124

  Daryanani, Deepak ^a   Plukker, John Th ^a   De Jong, Mirjam A ^a   Haaxma Reiche, Hannie ^a   Nap, Raoul ^a   Kuiper, Hilde ^a   Hoekstra, Harald J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Brain metastases; Head and neck; Melanoma; Risk factors; Survival

Indexed keywords

STEROID;

ADOLESCENT; ADULT; AGED; BRAIN METASTASIS; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; CHI SQUARE TEST; CHILD; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; MALE; MELANOMA; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; INCIDENCE; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; REGRESSION ANALYSIS; RISK FACTORS; SEX FACTORS; SKIN NEOPLASMS; SURVIVAL ANALYSIS;

EID: 18344375110     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-200504000-00006     Document Type: Conference Paper

References (30)

1. Jemal A, Devesa SS, Hartge P, Tucker MA. Recent trends in cutaneous melanoma incidence among whites in the United States. J Natl Cancer Inst 2001; 93:678-683.
2. MacKie RM, Bray CA, Hole DJ, Morris A, Nicolson M, Evans A, et al. Incidence of and survival from malignant melanoma in Scotland: an epidemiological study. Lancet 2002; 360:587-591.
3. Marrett LD, Nguyen HL, Armstrong BK. Trends in the incidence of cutaneous malignant melanoma in New South Wales, 1983-1996. Int J Cancer 2001; 92:457-462.
4. Visser O, Siesling S, van Dijck JAAM. Incidence of Cancer in The Netherlands 1999/2000. 11th Report of the Netherlands Cancer Registry (www.ikcnet.nl). Utrecht: Netherlands Cancer Registry; 2003, pp. 15-20.
5. Ames FC, Sugarbaker EV, Ballantyne AJ. Analysis of survival and disease control in stage I melanoma of the head and neck. Am J Surg 1976; 132:484-491.
6. Fisher SR, O'Brien CJ. Head and neck melanomas. In: Batch CM, Houghton AN, Sober AJ, Soong S (editors): Cutaneous Melanoma. St. Louis: Quality Medical Publishing; 2003, pp. 275-296.
7. MacKie RM, Hole D, Hunter JA, Rankin R, Evans A, McLaren K, et al. Cutaneous malignant melanoma in Scotland: incidence, survival, and mortality, 1979-94. The Scottish Melanoma Group. Br Med J 1997; 315:1117-1121.
8. Gershenwald JE, Balch CM, Soong SJ, Thompson JF. Prognostic factors and natural history. In: Balch CM, Houghton AN, Sober AJ, Soong SJ (editors): Cutaneous Melanoma, 4th edn. St, Louis, MO: Quality Medical Publishing Inc.; 2003, pp. 25-55.
9. Fisher SR. Elective, therapeutic, and delayed lymph node dissection for malignant melanoma of the head and neck: analysis of 1444 patients from 1970 to 1998. Laryngoscope 2002; 112:99-110.
10. Bullard DE, Cox EB, Seigler HF. Central nervous system metastases in malignant melanoma. Neurosurgery 1981; 8:26-30.
11. Schouten LJ, Rutten J, Huveneers HA, Twijnstra A. Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma. Cancer 2002; 94:2698-2705.
12. Balch CM, Buzaid AC, Soong SJ, Atkins MB, Cascinelli N, Coit DG, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 2001; 19:3635-3648.
13. Kroon BB, Bergman W, Coebergh JW, Ruiter DJ. Consensus on the management of malignant melanoma of the skin in The Netherlands. Dutch Melanoma Working Party. Melanoma Res 1999; 9:207-212.
14. Sampson JH, Carter JH Jr, Friedman AH, Seigler HF. Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma. J Neurosurg 1998; 88:11-20.
15. van de Vrie W, Eggermont AM, Van Putten WL, Wiggers T. Therapeutic lymphadenectomy in melanomas of the head and neck. Head Neck 1993; 15:377-381.
16. Retsas S, Gershuny AR. Central nervous system involvement in malignant melanoma. Cancer 1988; 61:1926-1934.
17. Amer MH, Al Sarraf M, Baker LH, Vaitkevicius VK. Malignant melanoma and central nervous system metastases: incidence, diagnosis, treatment and survival. Cancer 1978; 42:660-668.
18. Balch CM, Soong SJ, Murad TM, Smith JW, Maddox WA, Durant JR. A multifactorial analysis of melanoma. IV. Prognostic factors in 200 melanoma patients with distant metastases (stage III). J Clin Oncol 1983; 1:126-134.
19. Yu C, Chen JC, Apuzzo ML, O'Day S, Giannotta SL, Weber JS, et al. Metastatic melanoma to the brain: prognostic factors after gamma knife radiosurgery. Int J Radiat Oncol Biol Phys 2002; 52:1277-1287.
20. Azzola MF, Shaw HM, Thompson JF, Soong SJ, Scolyer RA, Watson GF, et al. Tumor mitotic rate is a more powerful prognostic indicator than ulceration in patients with primary cutaneous melanoma: an analysis of 3661 patients from a single center. Cancer 2003; 97:1488-1498.
21. Zettersten E, Sagebiel RW, Miller JR 3rd, Tallapureddy S, Leong SP, Kashani-Sabet M. Prognostic factors in patients with thick cutaneous melanoma (>4mm). Cancer 2002; 94:1049-1056.
22. Patchell RA, Tibbs PA, Walsh JW, Dempsey RJ, Maruyama Y, Kryscio RJ, et al. A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 1990; 322:494-500.
23. Vecht CJ, Haaxma-Reiche H, Noordijk EM, Padberg GW, Voormolen JH, Hoekstra FH, et al. Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery? Ann Neurol 1993; 33:583-590.
24. Konstadoulakis MM, Messaris E, Zografos G, Androulakis G, Karakousis C. Prognostic factors in malignant melanoma patients with solitary or multiple brain metastases. Is there a role for surgery? J Neurosurg Sci 2000; 44:211-218.
25. Wronski M, Arbit E. Surgical treatment of brain metastases from melanoma: a retrospective study of 91 patients. J Neurosurg 2000; 93:9-18.
26. Buchsbaum JC, Suh JH, Lee SY, Chidel MA, Greskovich JF, Barnett GH. Survival by radiation therapy oncology group recursive partitioning analysis class and treatment modality in patients with brain metastases from malignant melanoma: a retrospective study. Cancer 2002; 94:2265-2272.
27. Lavine SD, Petrovich Z, Cohen-Gadol AA, Masri LS, Morton DL, O'Day SJ, et al. Gamma knife radiosurgery for metastatic melanoma: an analysis of survival, outcome, and complications. Neurosurgery 1999; 44:59-64.
28. Ellerhorst J, Strom E, Nardone E, McCutcheon I. Whole brain irradiation for patients with metastatic melanoma: a review of 87 cases. Int J Radiat Oncol Biol Phys 2001; 49:93-97.
29. Van der Veen JPW. Melanoma of the skin. In: Otter R (editor). Guidelines for Diagnostics and Treatment of Premalignant and Malignant Diseases in the Comprehensive Cancer Center Region North-Netherlands (IKN). Groningen: Integraal Kankercentrum Noord-Nederland; 2003, pp. 457-481.
30. Landonio G, Sartore-Bianchi A, Giannetta L, Renga M, Riva M, Siena S. Controversies in the management of brain metastases: the role of chemotherapy. Forum (Genova) 2001; 11:59-74.